LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer's disease.

    Eteleeb, Abdallah M / Novotny, Brenna C / Tarraga, Carolina Soriano / Sohn, Christopher / Dhungel, Eliza / Brase, Logan / Nallapu, Aasritha / Buss, Jared / Farias, Fabiana / Bergmann, Kristy / Bradley, Joseph / Norton, Joanne / Gentsch, Jen / Wang, Fengxian / Davis, Albert A / Morris, John C / Karch, Celeste M / Perrin, Richard J / Benitez, Bruno A /
    Harari, Oscar

    PLoS biology

    2024  Volume 22, Issue 4, Page(s) e3002607

    Abstract: Unbiased data-driven omic approaches are revealing the molecular heterogeneity of Alzheimer disease. Here, we used machine learning approaches to integrate high-throughput transcriptomic, proteomic, metabolomic, and lipidomic profiles with clinical and ... ...

    Abstract Unbiased data-driven omic approaches are revealing the molecular heterogeneity of Alzheimer disease. Here, we used machine learning approaches to integrate high-throughput transcriptomic, proteomic, metabolomic, and lipidomic profiles with clinical and neuropathological data from multiple human AD cohorts. We discovered 4 unique multimodal molecular profiles, one of them showing signs of poor cognitive function, a faster pace of disease progression, shorter survival with the disease, severe neurodegeneration and astrogliosis, and reduced levels of metabolomic profiles. We found this molecular profile to be present in multiple affected cortical regions associated with higher Braak tau scores and significant dysregulation of synapse-related genes, endocytosis, phagosome, and mTOR signaling pathways altered in AD early and late stages. AD cross-omics data integration with transcriptomic data from an SNCA mouse model revealed an overlapping signature. Furthermore, we leveraged single-nuclei RNA-seq data to identify distinct cell-types that most likely mediate molecular profiles. Lastly, we identified that the multimodal clusters uncovered cerebrospinal fluid biomarkers poised to monitor AD progression and possibly cognition. Our cross-omics analyses provide novel critical molecular insights into AD.
    MeSH term(s) Alzheimer Disease/metabolism ; Alzheimer Disease/genetics ; Alzheimer Disease/pathology ; Humans ; Animals ; Brain/metabolism ; Brain/pathology ; Mice ; Transcriptome/genetics ; Proteomics/methods ; Male ; Biomarkers/metabolism ; Metabolomics/methods ; Machine Learning ; Female ; Disease Progression ; Aged ; Disease Models, Animal ; Multiomics
    Chemical Substances Biomarkers
    Language English
    Publishing date 2024-04-30
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2126776-5
    ISSN 1545-7885 ; 1544-9173
    ISSN (online) 1545-7885
    ISSN 1544-9173
    DOI 10.1371/journal.pbio.3002607
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Cell-free RNA signatures predict Alzheimer's disease.

    Cisterna-García, Alejandro / Beric, Aleksandra / Ali, Muhammad / Pardo, Jose Adrian / Chen, Hsiang-Han / Fernandez, Maria Victoria / Norton, Joanne / Gentsch, Jen / Bergmann, Kristy / Budde, John / Perlmutter, Joel S / Morris, John C / Cruchaga, Carlos / Botia, Juan A / Ibanez, Laura

    iScience

    2023  Volume 26, Issue 12, Page(s) 108534

    Abstract: There is a need for affordable, scalable, and specific blood-based biomarkers for Alzheimer's disease that can be applied to a population level. We have developed and validated disease-specific cell-free transcriptomic blood-based biomarkers composed by ... ...

    Abstract There is a need for affordable, scalable, and specific blood-based biomarkers for Alzheimer's disease that can be applied to a population level. We have developed and validated disease-specific cell-free transcriptomic blood-based biomarkers composed by a scalable number of transcripts that capture AD pathobiology even in the presymptomatic stages of the disease. Accuracies are in the range of the current CSF and plasma biomarkers, and specificities are high against other neurodegenerative diseases.
    Language English
    Publishing date 2023-11-23
    Publishing country United States
    Document type Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2023.108534
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer's disease.

    Cruchaga, Carlos / Ali, Muhammad / Shen, Yuanyuan / Do, Anh / Wang, Lihua / Western, Daniel / Liu, Menghan / Beric, Aleksandra / Budde, John / Gentsch, Jen / Schindler, Suzanne / Morris, John / Holtzman, David / Fernández, Maria / Ruiz, Agustín / Alvarez, Ignacio / Aguilar, Miquel / Pastor, Pau / Rutledge, Jarod /
    Oh, Hamilton / Wilson, Edward / Le Guen, Yann / Khalid, Rana / Robins, Chloe / Pulford, David / Ibanez, Laura / Wyss-Coray, Tony / Ju Sung, Yun

    Research square

    2024  

    Abstract: Changes in Amyloid-β (A), hyperphosphorylated Tau (T) in brain and cerebrospinal fluid (CSF) precedes AD symptoms, making CSF proteome a potential avenue to understand the pathophysiology and facilitate reliable diagnostics and therapies. Using the AT ... ...

    Abstract Changes in Amyloid-β (A), hyperphosphorylated Tau (T) in brain and cerebrospinal fluid (CSF) precedes AD symptoms, making CSF proteome a potential avenue to understand the pathophysiology and facilitate reliable diagnostics and therapies. Using the AT framework and a three-stage study design (discovery, replication, and meta-analysis), we identified 2,173 proteins dysregulated in AD, that were further validated in a third totally independent cohort. Machine learning was implemented to create and validate highly accurate and replicable (AUC>0.90) models that predict AD biomarker positivity and clinical status. These models can also identify people that will convert to AD and those AD cases with faster progression. The associated proteins cluster in four different protein pseudo-trajectories groups spanning the AD continuum and were enrichment in specific pathways including neuronal death, apoptosis and tau phosphorylation (early stages), microglia dysregulation and endolysosomal dysfuncton(mid-stages), brain plasticity and longevity (mid-stages) and late microglia-neuron crosstalk (late stages).
    Language English
    Publishing date 2024-02-16
    Publishing country United States
    Document type Preprint
    DOI 10.21203/rs.3.rs-3631708/v1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: MS4A4A modifies the risk of Alzheimer disease by regulating lipid metabolism and immune response in a unique microglia state.

    You, Shih-Feng / Brase, Logan / Filipello, Fabia / Iyer, Abhirami K / Del-Aguila, Jorge / He, June / D'Oliveira Albanus, Ricardo / Budde, John / Norton, Joanne / Gentsch, Jen / Dräger, Nina M / Sattler, Sydney M / Kampmann, Martin / Piccio, Laura / Morris, John C / Perrin, Richard J / McDade, Eric / Paul, Steven M / Cashikar, Anil G /
    Benitez, Bruno A / Harari, Oscar / Karch, Celeste M

    medRxiv : the preprint server for health sciences

    2023  

    Abstract: Genome-wide association studies (GWAS) have identified many modifiers of Alzheimer disease (AD) risk enriched in microglia. Two of these modifiers are common variants in ... ...

    Abstract Genome-wide association studies (GWAS) have identified many modifiers of Alzheimer disease (AD) risk enriched in microglia. Two of these modifiers are common variants in the
    Language English
    Publishing date 2023-02-08
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.02.06.23285545
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains.

    Novotny, Brenna C / Fernandez, Maria Victoria / Wang, Ciyang / Budde, John P / Bergmann, Kristy / Eteleeb, Abdallah M / Bradley, Joseph / Webster, Carol / Ebl, Curtis / Norton, Joanne / Gentsch, Jen / Dube, Umber / Wang, Fengxian / Morris, John C / Bateman, Randall J / Perrin, Richard J / McDade, Eric / Xiong, Chengjie / Chhatwal, Jasmeer /
    Goate, Alison / Farlow, Martin / Schofield, Peter / Chui, Helena / Karch, Celeste M / Cruchaga, Carlos / Benitez, Bruno A / Harari, Oscar

    Alzheimer's & dementia : the journal of the Alzheimer's Association

    2022  Volume 19, Issue 5, Page(s) 1785–1799

    Abstract: Introduction: The identification of multiple genetic risk factors for Alzheimer's disease (AD) suggests that many pathways contribute to AD onset and progression. However, the metabolomic and lipidomic profiles in carriers of distinct genetic risk ... ...

    Abstract Introduction: The identification of multiple genetic risk factors for Alzheimer's disease (AD) suggests that many pathways contribute to AD onset and progression. However, the metabolomic and lipidomic profiles in carriers of distinct genetic risk factors are not fully understood. The metabolome can provide a direct image of dysregulated pathways in the brain.
    Methods: We interrogated metabolomic signatures in the AD brain, including carriers of pathogenic variants in APP, PSEN1, and PSEN2 (autosomal dominant AD; ADAD), APOE ɛ4, and TREM2 risk variant carriers, and sporadic AD (sAD).
    Results: We identified 133 unique and shared metabolites associated with ADAD, TREM2, and sAD. We identified a signature of 16 metabolites significantly altered between groups and associated with AD duration.
    Discussion: AD genetic variants show distinct metabolic perturbations. Investigation of these metabolites may provide greater insight into the etiology of AD and its impact on clinical presentation.
    Highlights: APP/PSEN1/PSEN2 and TREM2 variant carriers show distinct metabolic changes. A total of 133 metabolites were differentially abundant in AD genetic groups. β-citrylglutamate is differentially abundant in autosomal dominant, TREM2, and sporadic AD. A 16-metabolite profile shows differences between Alzheimer's disease (AD) genetic groups. The identified metabolic profile is associated with duration of disease.
    MeSH term(s) Humans ; Alzheimer Disease/genetics ; Alzheimer Disease/pathology ; Amyloid beta-Protein Precursor/genetics ; Brain/pathology ; Heterozygote ; Lipidomics ; Mutation ; Presenilin-1/genetics
    Chemical Substances Amyloid beta-Protein Precursor ; Presenilin-1
    Language English
    Publishing date 2022-10-17
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2211627-8
    ISSN 1552-5279 ; 1552-5260
    ISSN (online) 1552-5279
    ISSN 1552-5260
    DOI 10.1002/alz.12800
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes.

    Olive, Claudia / Ibanez, Laura / Farias, Fabiana H Geraldo / Wang, Fengxian / Budde, John P / Norton, Joanne B / Gentsch, Jen / Morris, John C / Li, Zeran / Dube, Umber / Del-Aguila, Jorge / Bergmann, Kristy / Bradley, Joseph / Benitez, Bruno A / Harari, Oscar / Fagan, Anne / Ances, Beau / Cruchaga, Carlos / Fernandez, Maria Victoria

    Journal of Alzheimer's disease : JAD

    2020  Volume 77, Issue 4, Page(s) 1469–1482

    Abstract: Background: Rare variants in PLCG2 (p.P522R), ABI3 (p.S209F), and TREM2 (p.R47H, p.R62H) have been associated with late onset Alzheimer's disease (LOAD) risk in Caucasians. After the initial report, several studies have found positive results in cohorts ...

    Abstract Background: Rare variants in PLCG2 (p.P522R), ABI3 (p.S209F), and TREM2 (p.R47H, p.R62H) have been associated with late onset Alzheimer's disease (LOAD) risk in Caucasians. After the initial report, several studies have found positive results in cohorts of different ethnic background and with different phenotype.
    Objective: In this study, we aim to evaluate the association of rare coding variants in PLCG2, ABI3, and TREM2 with LOAD risk and their effect at different time points of the disease.
    Methods: We used a European American cohort to assess the association of the variants prior onset (using CSF Aβ42, tau, and pTau levels, and amyloid imaging as endophenotypes) and after onset (measured as rate of memory decline).
    Results: We confirm the association with LOAD risk of TREM2 p.R47H, p.R62H and ABI3 p.S209F variants, and the protective effect of PLCG2 p.P522R. In addition, ABI3 and TREM2 gene-sets showed significant association with LOAD risk. TREM2 p.R47H and PLCG2 p.P522R variants were also statistically associated with increase of amyloid imaging and AD progression, respectively. We did not observe any association of ABI3 p.S209F with any of the other AD endophenotypes.
    Conclusion: The results of this study highlight the importance of including biomarkers and alternative phenotypes to better understand the role of novel candidate genes with the disease.
    MeSH term(s) Adaptor Proteins, Signal Transducing/genetics ; Aged ; Aged, 80 and over ; Alzheimer Disease/diagnostic imaging ; Alzheimer Disease/genetics ; Cohort Studies ; Databases, Genetic/trends ; Female ; Genetic Variation/genetics ; Humans ; Male ; Membrane Glycoproteins/genetics ; Phenotype ; Phospholipase C gamma/genetics ; Receptors, Immunologic/genetics
    Chemical Substances ABI3 protein, human ; Adaptor Proteins, Signal Transducing ; Membrane Glycoproteins ; Receptors, Immunologic ; TREM2 protein, human ; PLCG2 protein, human (EC 3.1.4.3) ; Phospholipase C gamma (EC 3.1.4.3)
    Language English
    Publishing date 2020-09-03
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-200019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations.

    Dube, Umber / Del-Aguila, Jorge L / Li, Zeran / Budde, John P / Jiang, Shan / Hsu, Simon / Ibanez, Laura / Fernandez, Maria Victoria / Farias, Fabiana / Norton, Joanne / Gentsch, Jen / Wang, Fengxian / Salloway, Stephen / Masters, Colin L / Lee, Jae-Hong / Graff-Radford, Neill R / Chhatwal, Jasmeer P / Bateman, Randall J / Morris, John C /
    Karch, Celeste M / Harari, Oscar / Cruchaga, Carlos

    Nature neuroscience

    2019  Volume 22, Issue 11, Page(s) 1903–1912

    Abstract: Parietal cortex RNA-sequencing (RNA-seq) data were generated from individuals with and without Alzheimer disease (AD; ... ...

    Abstract Parietal cortex RNA-sequencing (RNA-seq) data were generated from individuals with and without Alzheimer disease (AD; n
    MeSH term(s) Alzheimer Disease/diagnosis ; Alzheimer Disease/metabolism ; Alzheimer Disease/pathology ; Atlases as Topic ; Case-Control Studies ; Gene Expression Profiling ; Humans ; MicroRNAs/metabolism ; Parietal Lobe/metabolism ; RNA, Circular/biosynthesis ; RNA, Messenger/biosynthesis ; Sequence Analysis, RNA ; Severity of Illness Index
    Chemical Substances MicroRNAs ; RNA, Circular ; RNA, Messenger
    Language English
    Publishing date 2019-10-07
    Publishing country United States
    Document type Journal Article ; Meta-Analysis ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1420596-8
    ISSN 1546-1726 ; 1097-6256
    ISSN (online) 1546-1726
    ISSN 1097-6256
    DOI 10.1038/s41593-019-0501-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top